Dustin Dinning, DO
Rheumatology · Coeur D Alene, IDNPI 1578774022
Payments from drug & device makers
Across 718 payments — averaging $433.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$143K
- AbbVie$111K
- Lilly USA, LLC$46K
- Novartis$8K
- E.r. Squibb & Sons, L.L.C.$1K
- AstraZeneca$513
- plus $2K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 302 | $143,373 |
| AbbVie | 206 | $110,628 |
| Lilly USA, LLC | 59 | $45,866 |
| Novartis | 34 | $8,296 |
| E.r. Squibb & Sons, L.L.C. | 14 | $1,010 |
| AstraZeneca(2 entities) | 22 | $513 |
| UCB, Inc. | 19 | $362 |
| Johnson & Johnson | 10 | $251 |
| GSK | 13 | $230 |
| Fresenius Kabi USA, LLC | 6 | $123 |
| Pfizer | 6 | $107 |
| ANI Pharmaceuticals, Inc. | 3 | $56 |
| Merck | 2 | $48 |
| Organon | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| Bayer | 2 | $43 |
| Mallinckrodt Hospital Products Inc. | 2 | $39 |
| Mallinckrodt Enterprises LLC | 2 | $36 |
| Aurinia Pharma U.S., Inc. | 1 | $28 |
| Sobi, Inc | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $24 |
| Tersera Therapeutics LLC | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $22 |
| Accord Healthcare, Inc. | 1 | $21 |
| Radius Health, Inc. | 1 | $18 |
| Boston Scientific | 1 | $17 |
| Pacira Therapeutics, Inc. | 1 | $16 |
| Spectrum Pharmaceuticals Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
How this compares
$311,324 in reported general payments places this provider in the 85th percentile of 28 rheumatology providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Coeur D Alene
- Craig WiesenhutterCoeur D Alene$79K
- Linda SakaiCoeur D Alene$3K
- Philip MeadowCoeur D Alene$2K
- Sheena HenryCoeur D Alene$2K
- William KnibbeBoise$925K
- Craig ScovilleIdaho Falls$753K
- James LovelessBoise$393K
- Christopher GibsonAshton$39K
- Achini DingmanMeridian$37K
- Peggy Ann RuppBoise$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.